Komen’s commitment to supporting life-saving research has never been stronger. As part of the Komen Affiliate Network, Komen Upstate New York contributes 25 percent of the net funds we raise to the Komen National Research Program. Through this commitment, we’re able to contribute vital funding to lifesaving research in all areas of breast cancer, from basic biology to prevention to treatment and to survivorship.
Some of the most pressing issues in breast cancer being supported by the Komen National Research Program today include:
- Identifying and improving methods of early detection
- Ensuring more accurate diagnoses
- Developing new approaches to prevention
- Enabling personalized treatments based on breast cancer subtypes and the genetic make-up of a tumor
Through our contribution to the Komen National Research Program, we are also supporting clinical trials in a broad range of areas that include:
- Identifying the causes of breast cancer
- New approaches to cancer prevention, including preventative drugs, nutritional approaches and changes in lifestyle and behavior
- New methods for early detection, screening and diagnosis of breast cancer including new technologies like ultrasound tomography and blood tests that measure biomarkers
- New approaches to surgery and radiation therapy
- New anticancer drugs for breast cancer, including chemotherapy, hormonal therapy, targeted therapy and immunotherapy agents
- New combinations of treatments
- Complementary and alternative cancer therapies
- Supportive care to understand the impact and identify the needs breast
National Research Re-Invested into Our Upstate New York Affiliate
Since 2001, OVER $12 MILLION in national Komen research funding has been awarded brought back into the communities we serve.
Recent funding awarded includes Roswell Park Comprehensive Care Center. In 2018 Subhamoy Dasgupta, Ph.D. received a $450,000 national Komen grant toward work to determine if blocking a protein will increase the effectiveness of current breast cancer treatments.
In 2017, Jun Zia, Ph.D, with The Research Foundation for SUNY on behalf of the University at Buffalo, received a $450,000 national Komen grant to develop new screening technology for women with dense breast tissue.
In 2017, John Lamar, PhD, with Albany Medical College, received a $450,000 national Komen grant to study metastatic breast cancer, and specifically, to investigate whether certain proteins, called YAP and TAZ, play a role in enabling the spread and subsequent growth of breast cancer cells in the body.